The Use of Vasopressors During Deceased Donor Pancreas Procurement Decreases the Risk of Pancreas Transplant Graft Failure
- PMID: 36395398
- DOI: 10.1097/MPA.0000000000002103
The Use of Vasopressors During Deceased Donor Pancreas Procurement Decreases the Risk of Pancreas Transplant Graft Failure
Abstract
Objectives: The objective of this study was to identify the effect of various vasopressors on pancreas graft failure and patient survival.
Methods: A retrospective analysis of the United Network for Organ Sharing database was performed between 2000 and 2019. Patient and graft survival rates were analyzed up to 5 years posttransplant.
Results: The data included 17,348 pancreas transplant recipients: 12,857 simultaneous pancreas-kidney, 1440 pancreas transplant alone, and 3051 pancreas-after-kidney transplant recipients. Use of dopamine during deceased donor procurement increased graft failure by 18% (hazard ratio [HR], 1.18; P < 0.001). Absence of vasopressor caused graft failure to rise by 8% (HR, 1.08; P = 0.09). Dopamine increased the mortality rate by 37% (HR, 1.37; P < 0.001) and the absence of vasopressor increased the mortality rate by 14% (HR, 1.14; P = 0.02). Phenylephrine and norepinephrine reduced the mortality rate by 10% (HR, 0.90; P = 0.05) and 11% (HR, 0.89; P = 0.10), respectively.
Conclusions: The absence of vasopressor use or the use of dopamine is associated with a higher risk of both pancreas transplant graft failure and recipient mortality. The use of phenylephrine and norepinephrine reduces the risk of mortality. This information should guide deceased donor hemodynamic support management in anticipation of pancreas procurement for future transplantation.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Kelly W, Lillehei R, Merkel F, et al. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery . 1967;61:827–837.
-
- Gruessner A, Sutherland D. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant . 2005;19:433–455.
-
- Giorgakis E, Mathur A, Chakkera H, et al. Solid pancreas transplant: pushing forward. World J Transplant . 2018;8:237–251.
-
- Gruessner AC, Sutherland DER, Gruessner RWG. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant . 2010;15:93–101.
-
- Chinnakotla S, Majumder K, Sutherland DE. Controversies in pancreas transplantation. Minerva Chir . 2015;70:57–62.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical